Bios Equity Partners, LP - Aug 13, 2021 Form 3 Insider Report for IN8BIO, INC. (INAB)

Role
10%+ Owner
Signature
Bios Equity Partners, LP By: Cavu Management, LP, its general partner By: Cavu Advisors, LLC, its general Partner By:/s/ Leslie W. Kreis, Jr., Manager
Stock symbol
INAB
Transactions as of
Aug 13, 2021
Transactions value $
$0
Form type
3
Date filed
8/17/2021, 07:24 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INAB Stock Option (right to buy) Aug 13, 2021 Common Stock 12.8K $1.07 By BP Directors, LP F1, F2, F5, F6
holding INAB Stock Option (right to buy) Aug 13, 2021 Common Stock 10.5K $10.00 By BP Directors, LP F3, F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of options to purchase 12,775 shares of common stock of the Issuer, par value $0.0001 per share, granted in consideration for Travis Whitfill's services as a director of the Issuer.
F2 Twenty-five percent (25%) of the shares subject to the option vested on March 15, 2020, and the remaining shares subject to the options vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to Mr. Whitfill continuing to provide services through each such date.
F3 Consists of options to purchase 10,500 shares of common stock of the Issuer, par value $0.0001 per share, granted in consideration for Mr. Whitfill's services as a director of the Issuer.
F4 One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on August 29, 2021 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to Mr. Whitfill continuing to provide services through each such date.
F5 Bios Equity Partners, LP ("Bios Equity I") is the general partner of BP Directors, LP ("Bios Directors").
F6 Pursuant to a preexisting agreement, Mr. Whitfill is deemed to hold the reported options for the benefit of Bios Directors. Bios Directors may be deemed the direct or indirect beneficial owner of the options, and Bios Equity I may be deemed the indirect beneficial owner of the options through its indirect interest in Bios Directors. Bios Directors and Bios Equity I each disclaim beneficial ownership of any of the reported securities except to the extent of their pecuniary interest therein.